+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Acute Graft-versus-Host Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Graft-versus-Host Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus Market by Drug Class, by Route of Administration, by Distribution Channel, and By Region - Product Thumbnail Image

Systemic Lupus Erythematosus Market by Drug Class, by Route of Administration, by Distribution Channel, and By Region

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Thumbnail Image

Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • May 2025
  • 134 Pages
  • Global
From
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • June 2025
  • 185 Pages
  • Global
From
Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • May 2025
  • 181 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 183 Pages
  • Global
From
Inflammatory Bowel Disease Treatment: Market Share, and Growth Analysis by Product Type (Biologics, Aminosalicylates, Corticosteroids, Immunomodulators), Application, End User, Technology - Product Thumbnail Image

Inflammatory Bowel Disease Treatment: Market Share, and Growth Analysis by Product Type (Biologics, Aminosalicylates, Corticosteroids, Immunomodulators), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Periodic Fever Syndrome Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Thumbnail Image

Periodic Fever Syndrome Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Rheumatoid Arthritis Therapeutics Market Report and Forecast 2025-2034 - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Crohn's Disease Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Thumbnail Image

Crohn's Disease Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Crohn's Disease (CD) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Crohn's Disease (CD) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Uveitis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Uveitis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Behcet's Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Behcet's Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Ulcerative Colitis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Ulcerative Colitis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Psoriatic Arthritis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Psoriatic Arthritis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more